Goldman Sachs’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Goldman Sachs’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,904	Closed	-$466K	–	6939
2026 Q1	$466K	Buy	+8,904	New	+$453K	﹤0.01%	5643
2017 Q2	–	Sell	-50,036	Closed	-$1.29M	–	6944
2017 Q1	$1.29M	Hold	50,036	–	–	﹤0.01%	4160
2016 Q4	$1.15M	Hold	50,036	–	–	﹤0.01%	4329
2016 Q3	$1.31M	Sell	50,036 -379	-0.8%	-$9.46K	﹤0.01%	4172
2016 Q2	$1.14M	Buy	+50,415	New	+$1.2M	﹤0.01%	4081

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Goldman Sachs's SBIO Position: Q2 2026 in Review

Goldman Sachs sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 8,904 shares — an estimated $466K sold.

Goldman Sachs first reported a position in SBIO in Q2 2016 and held it in 5 quarters. The position peaked at $1.31M in Q3 2016. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

Goldman Sachs reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
Goldman Sachs sold 8,904 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $466K.
Goldman Sachs first reported a position in ALPS Medical Breakthroughs ETF in Q2 2016 and held it in 5 quarters.
Goldman Sachs's ALPS Medical Breakthroughs ETF position peaked at $1.31M in Q3 2016.
66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.